Status
Conditions
Treatments
About
Gallium-68-DOTATOC binds primarily with high affinity to somatostatin subtype 2 (SSTR2) receptors and these somatostatin receptors are also overexpressed on inflammation cells when activated.
The hypothesis is that the GATED mode on a Gallium-68-DOTATOC cardiac recording would be able to highlight abnormalities that could be correlated with the age of the patients and their cardiovascular risk factors.
Full description
People with the selection criteria for the study, coming to the nuclear medicine department in order to benefit from a Gallium-68-DOTATOC PET/CT exam as part of a diagnostic or pre-therapeutic assessment of a neuroendocrine tumor will be offer to participate in the study After sign consent, patients were install in a room to have blood drawn for Troponin Ic, BNP and CRP and after Gallium-68-DOTATOC infusion Gallium-68-DOTATOC PET/CT will be recorded and immediately the cardiac record in Gated mode
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Persons who have received complete information on the organization of the research and who have signed the informed consent and:
Person for whom a 68Ga-DOTATOC PET/CT exam is requested as part of the diagnostic or pre-therapeutic assessment of a neuroendocrine tumour.
Exclusion criteria
Person with
Primary purpose
Allocation
Interventional model
Masking
99 participants in 1 patient group
Loading...
Central trial contact
VERONIQUE ROCH, MSc
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal